Five Years After Cannabis Legalization, Is It Time to Ease Restrictions on Promotion?
Healthc Policy
; 19(3): 21-28, 2024 Feb.
Article
em En
| MEDLINE
| ID: mdl-38721730
ABSTRACT
In the spring of 2024, the federal government is expected to report on its legislative review of the Cannabis Act (2018). One of the most contentious issues is whether to relax restrictions on cannabis promotion. This commentary describes the tension between the public health aims of legalization and the secondary aim of displacing the illicit market. We maintain that among jurisdictions that have legalized cannabis, Canada stands out as having the stated primary objective of safeguarding public health, and its restrictions on promotion are evidence-based and innovative. These measures must be preserved, even in the face of growing industry pressure to loosen them.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cannabis
/
Legislação de Medicamentos
Limite:
Humans
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article